Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001593968-23-001009

Director acquired 74,561 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WITTE OWEN N. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-13 Grant or award : show line 1 in the form +74,561 292,832 D
Loading xslF345X04/primary_01.xml…